Sauerbruch T, Holl J, Ruckdeschel G, Förstl J, Weinzierl M
Endoscopy. 1985 Sep;17(5):170-2. doi: 10.1055/s-2007-1018492.
Studies on the incidence of bacteraemia following endoscopic injection sclerotherapy produce equivocal results. Accordingly, we performed a prospective study in 24 patients who underwent a total of 40 sclerotherapy sessions. Blood was drawn before, during, and 5 minutes, 30 minutes, 3 hours and 24 hours after sclerotherapy. Transient bacteraemia (mostly during and 5 minutes after sclerotherapy) was detected in 21 (53%) procedures. The bacteraemic events bore no relation to febrile episodes. The most frequently isolated microorganisms were alpha-haemolytic Streptococcus spp. and coagulase-negative Staphylococcus spp.. We conclude that injection sclerotherapy is associated with a high incidence of bacteraemia which, however, in most cases is transient and does not lead to septic disease.
关于内镜注射硬化疗法后菌血症发生率的研究结果并不明确。因此，我们对24例患者进行了一项前瞻性研究，这些患者共接受了40次硬化疗法治疗。在硬化疗法前、治疗期间以及治疗后5分钟、30分钟、3小时和24小时采集血液样本。在21例（53%）治疗过程中检测到短暂菌血症（大多发生在硬化疗法期间及之后5分钟）。菌血症事件与发热发作无关。最常分离出的微生物是甲型溶血性链球菌属和凝固酶阴性葡萄球菌属。我们得出结论，注射硬化疗法与菌血症的高发生率相关，然而，在大多数情况下，菌血症是短暂的，不会导致败血症。
